Literature DB >> 30688043

Plasma Proteomics Analysis Reveals Dysregulation of Complement Proteins and Inflammation in Acquired Obesity-A Study on Rare BMI-Discordant Monozygotic Twin Pairs.

Navid Sahebekhtiari1, Mayank Saraswat2,3, Sakari Joenväärä2,3, Riikka Jokinen1, Alen Lovric4, Sanna Kaye1, Adil Mardinoglu4,5,6, Aila Rissanen1, Jaakko Kaprio7,8, Risto Renkonen2,3, Kirsi H Pietiläinen1,9.   

Abstract

PURPOSE: The purpose of this study is to elucidate the effect of excess body weight and liver fat on the plasma proteome without interference from genetic variation. EXPERIMENTAL
DESIGN: The effect of excess body weight is assessed in young, healthy monozygotic twins from pairs discordant for body mass index (intrapair difference (Δ) in BMI > 3 kg m-2 , n = 26) with untargeted LC-MS proteomics quantification. The effect of liver fat is interrogated via subgroup analysis of the BMI-discordant twin cohort: liver fat discordant pairs (Δliver fat > 2%, n = 12) and liver fat concordant pairs (Δliver fat < 2%, n = 14), measured by magnetic resonance spectroscopy.
RESULTS: Seventy-five proteins are differentially expressed, with significant enrichment for complement and inflammatory response pathways in the heavier co-twins. The complement dysregulation is found in obesity in both the liver fat subgroups. The complement and inflammatory proteins are significantly associated with adiposity measures, insulin resistance and impaired lipids. CONCLUSIONS AND CLINICAL RELEVANCE: The early pathophysiological mechanisms in obesity are incompletely understood. It is shown that aberrant complement regulation in plasma is present in very early stages of clinically healthy obese persons, independently of liver fat and in the absence of genetic variation that typically confounds human studies.
© 2019 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  acquired obesity; complement cascade; label-free proteomics; monozygotic twins; plasma proteomics

Mesh:

Substances:

Year:  2019        PMID: 30688043     DOI: 10.1002/prca.201800173

Source DB:  PubMed          Journal:  Proteomics Clin Appl        ISSN: 1862-8346            Impact factor:   3.494


  5 in total

Review 1.  Gastrointestinal Barrier Breakdown and Adipose Tissue Inflammation.

Authors:  Lediya Cheru; Charles F Saylor; Janet Lo
Journal:  Curr Obes Rep       Date:  2019-06

2.  Transglutaminases and Obesity in Humans: Association of F13A1 to Adipocyte Hypertrophy and Adipose Tissue Immune Response.

Authors:  Mari T Kaartinen; Mansi Arora; Sini Heinonen; Aila Rissanen; Jaakko Kaprio; Kirsi H Pietiläinen
Journal:  Int J Mol Sci       Date:  2020-11-05       Impact factor: 5.923

Review 3.  Omics Biomarkers in Obesity: Novel Etiological Insights and Targets for Precision Prevention.

Authors:  Krasimira Aleksandrova; Caue Egea Rodrigues; Anna Floegel; Wolfgang Ahrens
Journal:  Curr Obes Rep       Date:  2020-09

4.  Fibromyalgia in women: association of inflammatory plasma proteins, muscle blood flow, and metabolism with body mass index and pain characteristics.

Authors:  Bijar Ghafouri; Emelie Edman; Marie Löf; Eva Lund; Olof Dahlqvist Leinhard; Peter Lundberg; Mikael Fredrik Forsgren; Björn Gerdle; Huan-Ji Dong
Journal:  Pain Rep       Date:  2022-10-04

5.  F13A1 transglutaminase expression in human adipose tissue increases in acquired excess weight and associates with inflammatory status of adipocytes.

Authors:  M T Kaartinen; M Arora; S Heinonen; A Hang; A Barry; J Lundbom; A Hakkarainen; N Lundholm; A Rissanen; J Kaprio; K H Pietiläinen
Journal:  Int J Obes (Lond)       Date:  2020-11-21       Impact factor: 5.095

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.